{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T04:18:26Z","timestamp":1747714706264,"version":"3.40.5"},"reference-count":97,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,2,25]],"date-time":"2015-02-25T00:00:00Z","timestamp":1424822400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2015,2,25]],"date-time":"2015-02-25T00:00:00Z","timestamp":1424822400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med. Res. Rev."],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1002\/med.21340","type":"journal-article","created":{"date-parts":[[2015,2,25]],"date-time":"2015-02-25T10:55:50Z","timestamp":1424861750000},"page":"698-719","source":"Crossref","is-referenced-by-count":14,"title":["Curious Discoveries in Antiviral Drug Development: The Role of Serendipity"],"prefix":"10.1002","volume":"35","author":[{"given":"Erik","family":"De Clercq","sequence":"first","affiliation":[{"name":"Rega Institute for Medical Research; KU Leuven; Leuven Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,2,25]]},"reference":[{"key":"10.1002\/med.21340-BIB0001|med21340-cit-0001","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1142\/7677","volume-title":"Nobel Prizes and Life Sciences","author":"Norrby","year":"2010"},{"key":"10.1002\/med.21340-BIB0002|med21340-cit-0002","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/272583a0","article-title":"9-(2-Hydroxyethoxymethyl) guanine activity against viruses of the herpes group","volume":"272","author":"Schaeffer","year":"1978","journal-title":"Nature"},{"key":"10.1002\/med.21340-BIB0003|med21340-cit-0003","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1073\/pnas.74.12.5716","article-title":"Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanine","volume":"74","author":"Elion","year":"1977","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/med.21340-BIB0004|med21340-cit-0004","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJM197605272942201","article-title":"Adenine arabinoside therapy of herpes zoster in the immunosuppressed. NIAID collaborative antiviral study","volume":"294","author":"Whitley","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1002\/med.21340-BIB0005|med21340-cit-0005","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1128\/JVI.2.9.878-885.1968","article-title":"Antiviral activity of polyacrylic and polymethacrylic acids. I. Mode of action in vitro","volume":"2","author":"Somer","year":"1968","journal-title":"J Virol"},{"key":"10.1002\/med.21340-BIB0006|med21340-cit-0006","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1128\/JVI.2.9.886-893.1968","article-title":"Antiviral activity of polyacrylic and polymethacrylic acids. II. Mode of action in vivo","volume":"2","author":"Somer","year":"1968","journal-title":"J Virol"},{"key":"10.1002\/med.21340-BIB0007|med21340-cit-0007","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1128\/JVI.5.3.313-320.1970","article-title":"Polyacetal carboxylic acids: A new group of antiviral polyanions","volume":"5","author":"Claes","year":"1970","journal-title":"J Virol"},{"key":"10.1002\/med.21340-BIB0008|med21340-cit-0008","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/BF01965997","article-title":"Alopecia in laboratory animals induced by a polyampholyte, polyethylene alanine","volume":"36","author":"Clercq","year":"1980","journal-title":"Experientia"},{"key":"10.1002\/med.21340-BIB0009|med21340-cit-0009","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/2211058a0","article-title":"Loss of hair in experimental animals induced by cyclophosphamide","volume":"221","author":"Homan","year":"1969","journal-title":"Nature"},{"key":"10.1002\/med.21340-BIB0010|med21340-cit-0010","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/2261211a0","article-title":"RNA-dependent DNA polymerase in virions of Rous sarcoma virus","volume":"226","author":"Temin","year":"1970","journal-title":"Nature"},{"key":"10.1002\/med.21340-BIB0011|med21340-cit-0011","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/2261209a0","article-title":"RNA-dependent DNA polymerase in virions of RNA tumour viruses","volume":"226","author":"Baltimore","year":"1970","journal-title":"Nature"},{"key":"10.1002\/med.21340-BIB0012|med21340-cit-0012","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1126\/science.174.4011.840","article-title":"Simultaneous detection of reverse transcriptase and high molecular weight RNA unique to oncogenic RNA viruses","volume":"174","author":"Schlom","year":"1971","journal-title":"Science"},{"key":"10.1002\/med.21340-BIB0013|med21340-cit-0013","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0304-3835(79)90017-X","article-title":"Suramin: A potent inhibitor of the reverse transcriptase of RNA tumor viruses","volume":"8","author":"Clercq","year":"1979","journal-title":"Cancer Lett"},{"key":"10.1002\/med.21340-BIB0014|med21340-cit-0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0166-3542(87)90034-9","article-title":"Suramin in the treamtent of AIDS: Mechanism of action","volume":"7","author":"Clercq","year":"1987","journal-title":"Antiviral Res"},{"key":"10.1002\/med.21340-BIB0015|med21340-cit-0015","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1126\/science.6091268","article-title":"Suramin protection of T cells in vitro against infectivity and cytopathic effect of HTLV-III","volume":"226","author":"Mitsuya","year":"1984","journal-title":"Science"},{"key":"10.1002\/med.21340-BIB0016|med21340-cit-0016","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0006-291X(75)80361-5","article-title":"Inhibition of RNA-dependent DNA polymerase of murine oncornaviruses by ammonium-5-tungsto-2-antimoniate","volume":"65","author":"Chermann","year":"1975","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1002\/med.21340-BIB0017|med21340-cit-0017","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0140-6736(85)91162-6","article-title":"Antimoniotungstate (HPA 23) treatment of three patients with AIDS and one with prodrome","volume":"1","author":"Rozenbaum","year":"1985","journal-title":"Lancet"},{"key":"10.1002\/med.21340-BIB0018|med21340-cit-0018","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0140-6736(85)90002-9","article-title":"Effects of suramin on HTLV-III\/LAV infection presenting as Kaposi's sarcoma or AIDS-related complex: Clinical pharmacology and suppression of virus replication in vivo","volume":"2","author":"Broder","year":"1985","journal-title":"Lancet"},{"key":"10.1002\/med.21340-BIB0019|med21340-cit-0019","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0140-6736(85)92242-1","article-title":"Short-term results with suramin for AIDS-related conditions","volume":"1","author":"Rouvroy","year":"1985","journal-title":"Lancet"},{"key":"10.1002\/med.21340-BIB0020|med21340-cit-0020","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.1073\/pnas.82.20.7096","article-title":"3\u2019-Azido-3\u2019-deoxythymidine (BW A509U): An antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III\/lymphadenopathy-associated virus in vitro","volume":"82","author":"Mitsuya","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/med.21340-BIB0021|med21340-cit-0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.bi.57.070188.000245","article-title":"Sequences, sequences, and sequences","volume":"57","author":"Sanger","year":"1988","journal-title":"Annu Rev Biochem"},{"key":"10.1002\/med.21340-BIB0022|med21340-cit-0022","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1073\/pnas.74.12.5463","article-title":"DNA sequencing with chain-terminating inhibitors","volume":"74","author":"Sanger","year":"1977","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/med.21340-BIB0023|med21340-cit-0023","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0022-2836(78)90346-7","article-title":"The nucleotide sequence of bacteriophage phiX174","volume":"125","author":"Sanger","year":"1978","journal-title":"J Mol Biol"},{"key":"10.1002\/med.21340-BIB0024|med21340-cit-0024","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0022-2836(82)90546-0","article-title":"Nucleotide sequence of bacteriophage lambda DNA","volume":"162","author":"Sanger","year":"1982","journal-title":"J Mol Biol"},{"key":"10.1002\/med.21340-BIB0025|med21340-cit-0025","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1073\/pnas.83.6.1911","article-title":"Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III\/lymphadenopathy-associated virus (HTLV-III\/LAV) by 2\u2019,3\u2019-dideoxynucleosides","volume":"83","author":"Mitsuya","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/med.21340-BIB0026|med21340-cit-0026","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0006-291X(87)90460-8","article-title":"Both 2\u2019,3\u2019-dideoxythymidine and its 2\u2019,3\u2019-unsaturated derivative (2\u2019,3\u2019-dideoxythymidi\u00acnene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro","volume":"142","author":"Baba","year":"1987","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1002\/med.21340-BIB0027|med21340-cit-0027","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1016\/0006-2952(87)90253-X","article-title":"Potent and selective in vitro activity of 3\u2019-deoxythymidin-2\u2019-ene (3\u2019-deoxy-2\u2019,3\u2019-didehydrothymidine) against human immuno-deficiency virus","volume":"36","author":"Lin","year":"1987","journal-title":"Biochem Pharmacol"},{"key":"10.1002\/med.21340-BIB0028|med21340-cit-0028","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1128\/AAC.31.6.907","article-title":"Inhibitory effect of 2\u2019,3\u2019-didehydro-2\u2019,3\u2019-dideoxynucleosides on infectivity, cytopathic effects, and replication of human immunodeficiency virus","volume":"31","author":"Hamamoto","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/med.21340-BIB0029|med21340-cit-0029","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1128\/AAC.35.7.1386","article-title":"Anti-human immunodeficiency virus type 1 activity and in vitro toxicity of 2\u2019-deoxy-3\u2019-thiacytidine (BCH-189), a novel heterocyclic nucleoside analog","volume":"35","author":"Soudeyns","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/med.21340-BIB0030|med21340-cit-0030","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1128\/AAC.41.5.1082","article-title":"1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity","volume":"41","author":"Daluge","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/med.21340-BIB0031|med21340-cit-0031","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1128\/AAC.36.11.2423","article-title":"Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine","volume":"36","author":"Schinazi","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/med.21340-BIB0032|med21340-cit-0032","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrd703","article-title":"Strategies in the design of antiviral drugs","volume":"1","author":"Clercq","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"10.1002\/med.21340-BIB0033|med21340-cit-0033","doi-asserted-by":"crossref","first-page":"8333","DOI":"10.1073\/pnas.83.21.8333","article-title":"Phosphorylation of 3\u2019-azido-3\u2019-deoxythymidine and selective interaction of the 5\u2019-triphosphate with human immunodeficiency virus reverse transcriptase","volume":"83","author":"Furman","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/med.21340-BIB0034|med21340-cit-0034","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.bcp.2004.07.039","article-title":"Discovery and development of BVDU (brivudin) as a therapeutic for the treatment of herpes zoster","volume":"68","author":"Clercq","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1002\/med.21340-BIB0035|med21340-cit-0035","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1073\/pnas.76.6.2947","article-title":"E-5-(2-Bromovinyl)-2\u2019-deoxyuridine : A potent and selective antiherpes agent","volume":"76","author":"Clercq","year":"1979","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/med.21340-BIB0036|med21340-cit-0036","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1128\/AAC.17.1.8","article-title":"(E)-5-(2-Bromovinyl)-2\u2019-deoxyuridine in the treatment of experimental herpes simplex keratitis","volume":"17","author":"Maudgal","year":"1980","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/med.21340-BIB0037|med21340-cit-0037","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1136\/bmj.281.6249.1178","article-title":"Oral (E)-5-(2-bromovinyl)-2\u2019-deoxyuridine in severe herpes zoster infections","volume":"281","author":"Clercq","year":"1980","journal-title":"Brit Med J"},{"key":"10.1002\/med.21340-BIB0038|med21340-cit-0038","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1093\/nar\/12.4.2081","article-title":"Regeneration of an antiviral drug (E)-5-(2-bromovinyl)-2\u2019-de\u00acoxyuridine (BVDU) in vivo","volume":"12","author":"Desgranges","year":"1984","journal-title":"Nucleic Acids Res"},{"key":"10.1002\/med.21340-BIB0039|med21340-cit-0039","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00008571-199702000-00005","article-title":"Intestinal anaerobic bacteria hydrolyse sorivudine, producing the high blood concentration of 5-(E)-(2-bromovinyl)uracil that increases the level and toxicity of 5-fluorouracil","volume":"7","author":"Nakayama","year":"1997","journal-title":"Pharmacogenetics"},{"key":"10.1002\/med.21340-BIB0040|med21340-cit-0040","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1021\/jm000210m","article-title":"Highly potent and selective inhibition of varicella-zoster virus by bicyclic furopyrimidine nucleosides bearing an aryl side chain","volume":"43","author":"McGuigan","year":"2000","journal-title":"J Med Chem"},{"key":"10.1002\/med.21340-BIB0041|med21340-cit-0041","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1128\/AAC.49.3.1081-1086.2005","article-title":"Susceptibilities of several clinical varicella-zoster virus (VZV) isolates and drug-resistant VZV strains to bicyclic furano pyrimidine nucleosides","volume":"49","author":"Andrei","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/med.21340-BIB0042|med21340-cit-0042","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1128\/AAC.01446-10","article-title":"Pharmacokinetics and safety of FV-100, a novel oral anti-herpes zoster nucleoside analogue, administered in single and multiple doses to healthy young adult and elderly adult volunteers","volume":"55","author":"Pentikis","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/med.21340-BIB0043|med21340-cit-0043","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3851\/IMP1472","article-title":"FV-100: The most potent and selective anti-varicella zoster virus agent reported to date","volume":"20","author":"Migliore","year":"2010","journal-title":"Antivir Chem Chemother"},{"key":"10.1002\/med.21340-BIB0044|med21340-cit-0044","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/323464a0","article-title":"A novel selective broad-spectrum anti-DNA virus agent","volume":"323","author":"Clercq","year":"1986","journal-title":"Nature"},{"key":"10.1002\/med.21340-BIB0045|med21340-cit-0045","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1021\/ja01021a086","article-title":"The synthesis of 6\u2019-deoxyhomonucleoside-6\u2019-phosphonic acids","volume":"90","author":"Jones","year":"1968","journal-title":"J Am Chem Soc"},{"key":"10.1002\/med.21340-BIB0046|med21340-cit-0046","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1021\/jm00155a015","article-title":"Synthesis and antiherpes virus activity of phosphate and phosphonate derivatives of 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine","volume":"29","author":"Prisbe","year":"1986","journal-title":"J Med Chem"},{"key":"10.1002\/med.21340-BIB0047|med21340-cit-0047","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/nrd1877","article-title":"Acyclic nucleoside phosphonates : A key class of antiviral drugs","volume":"4","author":"Clercq","year":"2005","journal-title":"Nature Rev Drug Discov"},{"key":"10.1002\/med.21340-BIB0048|med21340-cit-0048","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJMoa021812","article-title":"Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B","volume":"348","author":"Hadziyannis","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1002\/med.21340-BIB0049|med21340-cit-0049","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa020681","article-title":"Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B","volume":"348","author":"Marcellin","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1002\/med.21340-BIB0050|med21340-cit-0050","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1056\/NEJMoa042957","article-title":"Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B","volume":"352","author":"Hadziyannis","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1002\/med.21340-BIB0051|med21340-cit-0051","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/0006-291X(89)92756-3","article-title":"Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative","volume":"165","author":"Baba","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1002\/med.21340-BIB0052|med21340-cit-0052","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1021\/jm00132a002","article-title":"A novel lead for specific anti-HIV-1 agents: 1-[(2-Hydroxyethoxy)methyl]-6-(phenylthio)thymine","volume":"32","author":"Miyasaka","year":"1989","journal-title":"J Med Chem"},{"key":"10.1002\/med.21340-BIB0053|med21340-cit-0053","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1073\/pnas.88.6.2356","article-title":"Potent and selective inhibition of human immunodeficiency virus type 1 (HIV-1) by 5-ethyl-6-phenylthiouracil derivatives through their interaction with the HIV-1 reverse transcriptase","volume":"88","author":"Baba","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/med.21340-BIB0054|med21340-cit-0054","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0026-895X(25)11080-8","article-title":"Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivatives","volume":"39","author":"Baba","year":"1991","journal-title":"Mol Pharmacol"},{"key":"10.1002\/med.21340-BIB0055|med21340-cit-0055","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0026-895X(25)09183-7","article-title":"Common features in the interaction of tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one and -thione and 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives with the human immunodeficiency virus type 1 reverse transcriptase","volume":"41","author":"Debyser","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1002\/med.21340-BIB0056|med21340-cit-0056","doi-asserted-by":"crossref","first-page":"11769","DOI":"10.1016\/S0021-9258(19)49764-0","article-title":"Kinetics of inhibition of endogenous human immunodeficiency virus type 1 reverse transcription by 2\u2019,3\u2019-dideoxynucleoside 5\u2019-triphosphate, tetrahydroimidazo-[4,5,1-jk][1,4]-benzodiazepin-2(1H)-thione, and 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives","volume":"267","author":"Debyser","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1002\/med.21340-BIB0057|med21340-cit-0057","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1128\/AAC.38.4.688","article-title":"Preclinical evaluation of MKC-442, a highly potent and specific inhibitor of human immunodeficiency virus type 1 in vitro","volume":"38","author":"Baba","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/med.21340-BIB0058|med21340-cit-0058","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/343470a0","article-title":"Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives","volume":"343","author":"Pauwels","year":"1990","journal-title":"Nature"},{"key":"10.1002\/med.21340-BIB0059|med21340-cit-0059","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1073\/pnas.88.4.1451","article-title":"An antiviral target on reverse transcriptase of human immunodeficiency virus type 1 revealed by tetrahydroimidazo-[4,5,1-jk][1,4]benzodiazepin-2(1H)-one and -thione derivatives","volume":"88","author":"Debyser","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/med.21340-BIB0060|med21340-cit-0060","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/0140-6736(91)90135-C","article-title":"Pharmacokinetics of R 82913 in patients with AIDS or AIDS-related complex","volume":"338","author":"Pialoux","year":"1991","journal-title":"Lancet"},{"key":"10.1002\/med.21340-BIB0061|med21340-cit-0061","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1128\/AAC.36.12.2661","article-title":"Pharmacokinetics of R 82913 in AIDS patients: A phase I dose-finding study of oral administration compared with intravenous infusion","volume":"36","author":"Wit","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/med.21340-BIB0062|med21340-cit-0062","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1021\/jm040840e","article-title":"In search of a novel anti-HIV drug: Multidisciplinary coordination in the discovery of 4-[[4-[[4-[(1E)-2-cyanoethenyl]-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile (R278474, rilpivirine)","volume":"48","author":"Janssen","year":"2005","journal-title":"J Med Chem"},{"key":"10.1002\/med.21340-BIB0063|med21340-cit-0063","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bcp.2012.03.024","article-title":"Where rilpivirine meets with tenofovir, the start of a new anti-HIV drug combination era","volume":"84","author":"Clercq","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1002\/med.21340-BIB0064|med21340-cit-0064","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0026-895X(25)09263-6","article-title":"Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents","volume":"42","author":"Yamamoto","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1002\/med.21340-BIB0065|med21340-cit-0065","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nrd1134","article-title":"The bicyclam AMD3100 story","volume":"2","author":"Clercq","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1002\/med.21340-BIB0066|med21340-cit-0066","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.1073\/pnas.89.12.5286","article-title":"Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event","volume":"89","author":"Clercq","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/med.21340-BIB0067|med21340-cit-0067","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1128\/AAC.38.4.668","article-title":"Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100","volume":"38","author":"Clercq","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/med.21340-BIB0068|med21340-cit-0068","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0166-3542(97)00025-9","article-title":"Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor fusin\/CXCR-4","volume":"35","author":"Schols","year":"1997","journal-title":"Antiviral Res"},{"key":"10.1002\/med.21340-BIB0069|med21340-cit-0069","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1084\/jem.186.8.1383","article-title":"Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4","volume":"186","author":"Schols","year":"1997","journal-title":"J Exp Med"},{"key":"10.1002\/med.21340-BIB0070|med21340-cit-0070","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/nm0198-072","article-title":"AMD3100, a small-molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor","volume":"4","author":"Donzella","year":"1998","journal-title":"Nat Med"},{"key":"10.1002\/med.21340-BIB0071|med21340-cit-0071","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1124\/mol.60.1.164","article-title":"Mutation of Asp(171) and Asp(262) of the chemokine receptor CXCR4 impairs its coreceptor function for human immunodeficiency virus-1 entry and abrogates the antagonistic activity of AMD3100","volume":"60","author":"Hatse","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1002\/med.21340-BIB0072|med21340-cit-0072","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1128\/AAC.44.6.1667-1673.2000","article-title":"Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers","volume":"44","author":"Hendrix","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/med.21340-BIB0073|med21340-cit-0073","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.bcp.2008.12.014","article-title":"The AMD3100 story: The path to the discovery of a stem cell mobilizer (Mozobil)","volume":"77","author":"Clercq","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1002\/med.21340-BIB0074|med21340-cit-0074","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.pharmthera.2010.08.009","article-title":"Recent advances on the use of the CXCR4 antagonist plerixafor (AMD3100, Mozobil\u2122) and potential of other CXCR4 antagonists as stem cell mobilizers","volume":"128","author":"Clercq","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1002\/med.21340-BIB0075|med21340-cit-0075","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1182\/blood-2003-02-0663","article-title":"Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist","volume":"102","author":"Liles","year":"2003","journal-title":"Blood"},{"key":"10.1002\/med.21340-BIB0076|med21340-cit-0076","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.bbmt.2013.01.005","article-title":"Plerixafor plus granulocyte colony-stimulating factor improves the mobilization of hematopoietic stem cells in patients with non-Hodgkin lymphoma and low circulating peripheral blood CD34+ cells","volume":"19","author":"Maziarz","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1002\/med.21340-BIB0077|med21340-cit-0077","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1537-2995.2012.03744.x","article-title":"A specific time course for mobilization of peripheral blood CD34+ cells after plerixafor injection in very poor mobilizer patients: Impact on the timing of the apheresis procedure","volume":"53","author":"Lefr\u00e8re","year":"2013","journal-title":"Transfusion"},{"key":"10.1002\/med.21340-BIB0078|med21340-cit-0078","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1111\/trf.12102","article-title":"The evolving role of plerixafor in hematopoietic progenitor cell mobilization","volume":"53","author":"Tanhehco","year":"2013","journal-title":"Transfusion"},{"key":"10.1002\/med.21340-BIB0079|med21340-cit-0079","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1021\/jm00348a004","article-title":"Carbocyclic analogue of 3-deazaadenosine: A novel antiviral agent using S-adenosylhomocysteine hydrolase as a pharmacological target","volume":"25","author":"Montgomery","year":"1982","journal-title":"J Med Chem"},{"key":"10.1002\/med.21340-BIB0080|med21340-cit-0080","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1080\/15257770500265638","article-title":"John Montgomery's legacy: Carbocyclic adenosine analogues as SAH hydrolase inhibitors with broad-spectrum antiviral activity","volume":"24","author":"Clercq","year":"2005","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1002\/med.21340-BIB0081|med21340-cit-0081","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1016\/S0021-9258(17)43053-5","article-title":"Neplanocin A. A potent inhibitor of S-adenosylhomocysteine hydrolase and of vaccinia virus multiplication in mouse L929 cells","volume":"259","author":"Borchardt","year":"1984","journal-title":"J Biol Chem"},{"key":"10.1002\/med.21340-BIB0082|med21340-cit-0082","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0166-3542(83)90011-6","article-title":"Broad-spectrum antiviral activity of the carbocyclic analog of 3-deazaadenosine","volume":"3","author":"Clercq","year":"1983","journal-title":"Antiviral Res"},{"key":"10.1002\/med.21340-BIB0083|med21340-cit-0083","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1128\/AAC.28.1.84","article-title":"Antiviral and antimetabolic activities of neplanocins","volume":"28","author":"Clercq","year":"1985","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/med.21340-BIB0084|med21340-cit-0084","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1128\/AAC.33.8.1291","article-title":"Broad-spectrum antiviral activities of neplanocin A, 3-deazaneplanocin A, and their 5\u2019-nor derivatives","volume":"33","author":"Clercq","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/med.21340-BIB0085|med21340-cit-0085","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1021\/jm00127a007","article-title":"Synthesis of 3-deazaneplanocin A, a powerful inhibitor of S-adenosylhomocysteine hydrolase with potent and selective in vitro and in vivo antiviral activities","volume":"32","author":"Tseng","year":"1989","journal-title":"J Med Chem"},{"key":"10.1002\/med.21340-BIB0086|med21340-cit-0086","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/0006-291X(85)91438-X","article-title":"Antiviral potency of adenosine analogues: Correlation with inhibition of S-adenosylhomocysteine hydrolase","volume":"129","author":"Clercq","year":"1985","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1002\/med.21340-BIB0087|med21340-cit-0087","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1016\/0006-2952(87)90533-8","article-title":"S-Adenosylhomocysteine hydrolase inhibitors as broad-spectrum antiviral agents","volume":"36","author":"Clercq","year":"1987","journal-title":"Biochem Pharmacol"},{"key":"10.1002\/med.21340-BIB0088|med21340-cit-0088","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0166-3542(00)00066-8","article-title":"Treatment of lethal Ebola virus infection in mice with a single dose of an S-adenosyl-L-homocysteine hydrolase inhibitor","volume":"45","author":"Bray","year":"2000","journal-title":"Antiviral Res"},{"key":"10.1002\/med.21340-BIB0089|med21340-cit-0089","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0166-3542(02)00018-9","article-title":"3-Deazaneplanocin A induces massively increased interferon-\u03b1 production in Ebola virus-infected mice","volume":"55","author":"Bray","year":"2002","journal-title":"Antiviral Res"},{"key":"10.1002\/med.21340-BIB0090|med21340-cit-0090","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1021\/jm011095y","article-title":"6-[2-(Phosphonomethoxy)alkoxy]pyrimidines with antiviral activity","volume":"45","author":"Hol\u00fd","year":"2002","journal-title":"J Med Chem"},{"key":"10.1002\/med.21340-BIB0091|med21340-cit-0091","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1081\/NCN-200059772","article-title":"Antiviral potential of a new generation of acyclic nucleoside phosphonates, the 6-[2-(phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines","volume":"34","author":"Clercq","year":"2005","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1002\/med.21340-BIB0092|med21340-cit-0092","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1128\/AAC.46.7.2185-2193.2002","article-title":"Antiretrovirus activity of a novel class of acyclic pyrimidine nucleoside phosphonates","volume":"46","author":"Balzarini","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/med.21340-BIB0093|med21340-cit-0093","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1021\/jm030932o","article-title":"5-Substituted-2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]pyrimidines-acyclic nucleoside phosphonate analogues with antiviral activity","volume":"46","author":"Hockov\u00e1","year":"2003","journal-title":"J Med Chem"},{"key":"10.1002\/med.21340-BIB0094|med21340-cit-0094","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1128\/AAC.49.3.1177-1180.2005","article-title":"Novel acyclic nucleoside phosphonate analogues with potent anti-hepatitis B virus activities","volume":"49","author":"Ying","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/med.21340-BIB0095|med21340-cit-0095","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1016\/j.bmc.2004.04.002","article-title":"Synthesis and antiviral activity of 2,4-diamino-5-cyano-6-[2-(phosphonomethoxy)ethoxy]pyrimidine and related compounds","volume":"12","author":"Hockov\u00e1","year":"2004","journal-title":"Bioorg Med Chem"},{"key":"10.1002\/med.21340-BIB0096|med21340-cit-0096","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jac\/dkl454","article-title":"Pronounced in vitro and in vivo antiretroviral activity of 5-substituted 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy] pyrimidines","volume":"59","author":"Balzarini","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1002\/med.21340-BIB0097|med21340-cit-0097","doi-asserted-by":"crossref","first-page":"12101","DOI":"10.1074\/jbc.M109.096529","article-title":"The acyclic 2,4-diaminopyrimidine nucleoside phosphonate acts as a purine mimetic in HIV-1 reverse transcriptase DNA polymerization","volume":"285","author":"Herman","year":"2010","journal-title":"J Biol Chem"}],"container-title":["Medicinal Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmed.21340","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmed.21340","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/med.21340\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:35:32Z","timestamp":1747701332000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/med.21340"}},"subtitle":["CURIOUS DISCOVERIES IN ANTIVIRAL DRUG DEVELOPMENT"],"short-title":[],"issued":{"date-parts":[[2015,2,25]]},"references-count":97,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,7]]}},"URL":"https:\/\/doi.org\/10.1002\/med.21340","archive":["Portico"],"relation":{},"ISSN":["0198-6325"],"issn-type":[{"type":"print","value":"0198-6325"}],"subject":[],"published":{"date-parts":[[2015,2,25]]}}}